Category: Co-develop
Shots: The collaboration will expand AstraZeneca’s portfolio of targeted therapies for cancer & other diseases. Thermo Fisher currently offers the NGS CDx solution which is approved and reimbursed by government & commercial insurers in 15+ countries, including the US, EU, Japan, South Korea & Middle East The agreement also provides the technology, expertise & ability […]
Shots: Wanchunbulin to receive $30M up front, $170M as regulatory and sales milestone & is eligible to receive $15M as equity investment at a pre-money valuation of $560M Hengrui gets exclusive rights to commercialize & co-develop plinabulin in Greater China and will be accountable for all costs associated with the commercialization of plinabulin in the […]
Shots: NovaRock to receive $7.5M up front and is eligible to receive ~$633M as development & sales milestones along with royalties on the sales of the licensed products in the Territory Flame gets the exclusive rights to NBL-015 for pancreatic and gastric cancer outside of Greater China including mainland China, Hong Kong, Macau, and Taiwan […]